Abstract:The high prevalence of infectious diseases in Africa, combined with weak healthcare systems, poor antimicrobial stewardship, and an unchecked drug supply chain, is steadily reversing the trend in the fight against infectious diseases in this part of the world, posing severe threats to antimicrobial resistance (AMR). AMR continuously evolves and threatens to undermine antimicrobial efficacy and undo advances against infectious diseases. This brewing pandemic is now recognized as a significant worldwide health danger, implicated in several cases of morbidity, mortality, and increasing healthcare costs. Vaccine technology has been proven to be the principal remedy to this imminent danger since it prevents microbial infections. However, since Africa cannot produce its vaccines, it relies on external sources and, as a result, it is significantly affected by vaccine nationalism, hoarding, and instabilities in global supply chains. This has further adversely impacted the ability of African governments to regulate rollouts, protect their citizens, and ultimately rejoin the global economy. This dependency is a severe challenge to Africa's health resilience, as it is unsustainable. Given the inevitability of potential global pandemics and the alarming incidences of multi-drug resistance infections reported daily, Africa must develop the capability to produce its vaccines. The review utilized a systematic search of academic databases and grey literature, as well as a manual search of relevant reports and articles. In this review, we outline the public health threats and concerns that AMR poses to Africans, and the hurdles and advances achieved in vaccine development over the years. We also highlight possible strategies, particularly collaborative efforts, that will accelerate vaccine production and ease the strain of infectious diseases and antimicrobial resistance in Africa. Key findings indicate that Africa has significant gaps in its vaccine manufacturing and distribution capacity, with only a few countries having the ability to produce vaccines. Additionally, existing vaccine production facilities are often outdated and require significant investment to meet international standards. The review also highlights successful initiatives in Africa, such as the mRNA vaccine hub and the African Vaccine Manufacturing Initiative, which have demonstrated the potential for building local vaccine manufacturing capacity. The study concludes that Africa needs to prioritize investment in vaccine research and development, regulatory capacity, and infrastructure to build a sustainable vaccine manufacturing ecosystem. Overall, this review emphasizes the urgent need for Africa to develop its vaccine manufacturing capacity to improve vaccine access and strengthen its ability to respond to future pandemics. The findings underscore the importance of collaboration between African governments, international organizations, and the private sector to build a resilient vaccine ecosystem in Africa.

COVID-19 vaccines development in Africa: a review of current situation and existing challenges of vaccine production

Advancing Vaccinology Capacity: Education and Efforts in Vaccine Development and Manufacturing across Africa

The need for Africa to develop capacity for vaccinology as a means of curbing antimicrobial resistance

COVID-19 vaccine equity in Africa

Progress with COVID-19 vaccination in the WHO African Region in 2021

Local Production of COVID-19 Vaccines: A Strategy for Action

Strengthening Africa’s capacity for vaccine research: Needs and challenges

Who Will Pay for the COVID-19 Vaccines for Africa?

Upstream factors impacting COVID-19 vaccination rates across Africa: A systematic review protocol

COVID-19 vaccine inequity in African low-income countries

COVID-19 Vaccines: Ensuring Social Justice and Health Equity among Refugees in Africa

Applications of Telemedicine in the Supply and Distribution of COVID-19 Vaccines in Africa

Will people in conflict affected zones in Africa have access to COVID-19 vaccine? A case of Nigeria

Vaccination Communication Strategies and Uptake in Africa: A Systematic Review

Will Africans take COVID-19 vaccination?

Challenges and Progress in Vaccine Development for COVID-19 Coronavirus (SARS-CoV-2): A Review

COVID-19 vaccinations in The Gambia: efforts, challenges, and future directions

Advancing Immunization in Africa: Overcoming Challenges to Achieve the 2030 Global Immunization Targets

Status Report on COVID-19 Vaccines Development

Factors, enablers and challenges for COVID-19 vaccine development

A review of prospective pathways and impacts of COVID-19 on the accessibility, safety, quality, and affordability of essential medicines and vaccines for universal health coverage in Africa